Krista Goodman

Krista Goodman, Ph.D., is Chief Scientific Officer. She secured both a MS and Ph.D. in Chemistry at Harvard University studying synthetic organic chemistry in the labs of Dave Evans while working on natural products total synthesis. Prior to Larkspur, Krista spent 20 years at GSK, most recently as Global Head and Senior Director of Flexible Medicinal Chemistry, Medicine Design. During her tenure at GSK, Krista served in global leadership roles where her groups were accountable for delivering drug leads and candidates across GSK’s entire portfolio, including oncology and immunology as well as infectious diseases and other areas of focus. She was also accountable for GSK’s chemistry outsourcing strategy and global lab operations. Additionally, while leading a newly formed early discover chemistry group at GSK, Krista and her team prosecuted over fifty different targets across the full spectrum of target classes, therapeutic areas, and small molecule modalities. She also has extensive experience with enzymes and kinases.